Jump to search

April 2018arrow

Primo "Lucky" Lara named UC Davis Comprehensive Cancer Center Director

April 3, 2018

Primo Nery Lara, Jr. has been named director of the National Cancer Institute-designated UC Davis Comprehensive Cancer Center, leading a team of more than 300 scientists with an estimated $90 million in annual research funding and a clinical enterprise that serves more than 10,000 adult and pediatric patients throughout the region every year.

March 2018arrow

Christopher Evans awarded top honor by the European Association of Urology

March 13, 2018

Christopher Evans, professor and chair of the UC Davis Department of Urology and president of the Society of Urologic Oncology, will receive the Platinum Award at the International Friendship Dinner on Sunday, March 18 during the 33rd annual European Association of Urology (EAU) meeting in Copenhagen, Denmark.

Primo Lara to become new deputy chair of SWOG

March 9, 2018

Primo “Lucky” Lara, Jr. will become the new deputy chair of SWOG, a research organization of more than 12,000 people at over 1,000 hospitals and clinics that designs and conducts publicly funded cancer clinical trials and that represents a major force cancer advances worldwide.  

Acute myeloid leukemia patients have reduced early mortality at NCI-designated cancer centers

March 8, 2018

Researchers at UC Davis have shown that patients with acute myeloid leukemia (AML) who received their care at a National Cancer Institute (NCI) cancer center in California had a dramatically reduced risk of early mortality. Using data from the California Cancer Registry and the Patient Discharge Dataset, the team determined that the risk was reduced by 53 percent. These findings were reported in February in the journal Cancer.

February 2018arrow

Young cancer survivors' risk of heart disease related to race and socioeconomic factors

February 9, 2018

Adolescent and young adult cancer survivors who are African American, poor or have public or no health insurance are far more likely to suffer from coronary artery disease, heart failure or stroke later in life than non-Hispanic white cancer survivors.

January 2018arrow

UC Davis researcher urges caution on engineered stem cells

January 3, 2018

In a commentary published today in the New England Journal of Medicine, UC Davis researcher William Murphy expressed cautious optimism about efforts to genetically engineer hematopoietic stem cells (HSCs) to temporarily resist cell death during transplantation. While these gene therapy approaches could dramatically improve patient outcomes, Murphy argues that their risks must be carefully studied in diverse animal models.

December 2017arrow

New grant funds study of immune cell activity in stem cell transplantation

December 21, 2017

A team of UC Davis investigators has been awarded a $1.2 million grant to examine a common virus and its effects on immune system function after stem cell transplantation.

Enhanced natural killer cells attack solid tumors

December 19, 2017

Human and veterinary researchers at UC Davis and other institutions have shown that enhanced natural killer (NK) immune cells, combined with radiation therapy, can be effective against spontaneous osteosarcoma (bone cancer) in dogs. The research showed these NK cells homed in on cancer and reduced metastasis in the treated dogs, offering a potential immunotherapy against solid tumors. The study was published today in the Journal for Immunotherapy of Cancer

November 2017arrow

In cancer, talking about bad news can be good

November 17, 2017

Giving bad news is never easy, especially when it’s life or death. But when an oncologist delivers a poor prognosis to a cancer patient, does it harm their relationship?  Some research studies have suggested it can.

Unlocking the genetics of cancer

November 7, 2017

For many, breast cancer is more than just a disease – it’s personal. One in eight women will be diagnosed with breast cancer at some point in their lives. But through new discoveries at the genetic level, the personal nature of cancer will eventually be what helps to beat it.

October 2017arrow

Peers can reduce tobacco use among younger smokers

October 25, 2017

Participating in a brief intervention delivered by their peers in community settings can help reduce smoking among youth and young adults, a new study from a team of tobacco-cessation researchers shows.

Moonshot grant advances immune therapy for dogs - and one day people - with cancer

October 20, 2017

UC Davis has received its first National Cancer Institute (NCI) Moonshot grant  ̶  $2.5 million over five years  ̶  to explore immunotherapy treatments for dogs who develop melanoma and osteosarcoma and that may one day benefit humans, as well.

Cancer Center hosts lung cancer research conference

October 19, 2017

Members of the UC Davis Comprehensive Cancer Center lung cancer treatment team will present at WCLC 2017, a one-day conference on Saturday, Nov. 11, from 7 a.m. to 4 p.m. in San Francisco. Presenters will share the latest lung cancer and other thoracic malignancy advances highlighted at the recent 18th Annual World Conference on Lung Cancer in Japan.

"Smart" immune cells: Emerging cancer therapy research at UC Davis receives a boost with NIH award

October 6, 2017

Assistant Professor Sean Collins, Department of Microbiology and Molecular Genetics, has received a $1.5 million award from the National Institutes of Health to advance the development of “smart” immune cells for therapies to treat cancer and other diseases. The five-year NIH Director’s New Innovator Award aims to provide new insight into how to engineer immune cells to control their recruitment and response to tumors.

2017-2018 Human Genomics Seminar Series starts Oct. 4

October 3, 2017

UC Davis Children's Hospital, UC Davis Comprehensive Cancer Center and the UC Davis Genome Center are hosting the 2017-2018 Human Genomics Seminar Series, a monthly series focusing on genomic medicine topics, led by UC Davis faculty. Seminars will be held the first Wednesday of every month at noon at the Center for Health and Technology, room 1341.

September 2017arrow

UC Davis receives $8 million to expand access to stem cell clinical trials

September 28, 2017

The California Institute for Regenerative Medicine today awarded a nearly $8 million grant to University of California, Davis, stem cell researchers to launch a special clinical trials program in Sacramento to accelerate the therapeutic development and delivery of stem cell therapies in human patients.

$3.3 million grant funds early detection of pancreatic cancer

September 27, 2017

UC Davis researchers, led by Julie Sutcliffe, have received a $3.3 million grant from the National Institutes of Health to advance efforts to diagnose pancreatic cancer before it spreads.

August 2017arrow

Knoepfler awarded second Alex's Lemonade Stand research grant

August 30, 2017

UC Davis stem cell scientist Paul Knoepfler has been awarded a second $250,000 grant for glioma research from an organization begun 15 years ago by a 5-year-old girl with a deadly form of childhood cancer.

Before sarcoma surgery - radiation

August 18, 2017

UC Davis researchers have shown that radiation therapy before surgery improves overall survival for patients with soft tissue sarcomas. This pre-surgical, or neoadjuvant, radiotherapy allows surgeons to get better margins around tumors and remove even microscopic cancer tissue more often. The study was published recently  in the Annals of Surgical Oncology.

One of America's top hospitals

August 8, 2017

U.S. News & World Report, which annually recognizes hospitals that excel in treating patients with serious and challenging injuries and illnesses, has again ranked UC Davis Medical Center as one of the nation's best hospitals.

Leader in cross-cultural care heads general medicine at UC Davis Health

August 1, 2017

Shin-Ping Tu, a national expert on improving health care delivery and cross-cultural medical care, has become chief of the Division of General Medicine at UC Davis Health. She leads a team of nearly 40 physicians who provide comprehensive treatment to adults and research innovative ways to advance patient care, train physicians and improve health policy.

July 2017arrow

Massive study launched to test personalized approach to breast cancer screening

July 26, 2017

Sorting out when or whether to get mammograms can be perplexing for any woman, and a health provider’s advice may not settle the matter. That’s because even experts disagree about when screening mammography is appropriate and for whom.

June 2017arrow

UC Davis Health hosts migrant student workshop

June 20, 2017

UC Davis Health welcomes 145 migrant high school students Sunday, June 25 for a day of tours, talks and opportunities to learn more about medical science from students, fellows and faculty.

How treating a dog's tumors may help in the fight against human cancer

June 6, 2017

With its internationally renowned school of veterinary medicine and its NCI-designated comprehensive cancer center, UC Davis is uniquely positioned to harness the power of each to tackle one of life’s greatest challenges: cancer.

Gandara named "Giant of Cancer Care"

June 2, 2017

David R. Gandara, professor and director of thoracic oncology at UC Davis Comprehensive Cancer Center, has been named a “Giant of Cancer Care” in lung cancer by OncLive in recognition of his work to advance the field of oncology through his contributions in research and clinical practice.

May 2017arrow

UC Davis signs agreement to license novel CT scanning technology

May 24, 2017

UC Davis has signed a licensing agreement providing Isotropic Imaging Corporation the rights to commercialize a novel computed tomography (CT) scanner that has the potential to improve breast cancer detection and positively impact women’s health.

In Memoriam: Robert E. Chason, former UC Davis Medical Center CEO

May 10, 2017

Former UC Davis Medical Center Chief Executive Officer Robert E. Chason passed away on May 8, 2017, following a brief illness. He was 73.